Bioceltix S.A.

WSE:BCX Stock Report

Market Cap: zł473.2m

Bioceltix Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Lukasz Bzdzion

Chief executive officer

zł522.3k

Total compensation

CEO salary percentage93.85%
CEO tenureno data
CEO ownership7.4%
Management average tenureno data
Board average tenure3.7yrs

Recent management updates

Recent updates

We're Not Very Worried About Bioceltix's (WSE:BCX) Cash Burn Rate

Mar 05
We're Not Very Worried About Bioceltix's (WSE:BCX) Cash Burn Rate

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Jun 15
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

Jan 19
Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Sep 21
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

May 09
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

CEO Compensation Analysis

How has Lukasz Bzdzion's remuneration changed compared to Bioceltix's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-zł14m

Mar 31 2025n/an/a

-zł14m

Dec 31 2024zł522kzł490k

-zł15m

Sep 30 2024n/an/a

-zł16m

Jun 30 2024n/an/a

-zł16m

Mar 31 2024n/an/a

-zł15m

Dec 31 2023zł713kn/a

-zł14m

Sep 30 2023n/an/a

-zł13m

Jun 30 2023n/an/a

-zł12m

Mar 31 2023n/an/a

-zł10m

Dec 31 2022zł368kzł368k

-zł9m

Sep 30 2022n/an/a

-zł8m

Jun 30 2022n/an/a

-zł5m

Mar 31 2022n/an/a

-zł5m

Dec 31 2021zł269kn/a

-zł4m

Compensation vs Market: Lukasz's total compensation ($USD143.64K) is about average for companies of similar size in the Polish market ($USD161.72K).

Compensation vs Earnings: Lukasz's compensation has been consistent with company performance over the past year.

CEO

Lukasz Bzdzion

no data
Tenure
zł522,347
Compensation

Mr. Lukasz Bzdzion is President of the Management Board of Bioceltix S.A. A biotechnologist and molecular biologist. An intern at the prestigious Medical College of Georgia (Center of Biotechnology and Gen...

Board Members

NamePositionTenureCompensationOwnership
Maciej Wieloch
Member of Supervisory Boardno datazł33.72kno data
Piotr Lembas
Member of Supervisory Board3.7yrszł59.40kno data
Aleksandra Klimczak
Member of Scientific Boardno datano datano data
Arkadiusz Miazek
Member of Scientific Boardno datano datano data
Maciej Przewozny
Member of Scientific Boardno datano datano data
Marcin Sieczek
Supervisory Board Memberno datazł34.22kno data
Ewelina Pawlus-Czerniejewska
Chairman of Supervisory Board3.7yrszł59.40kno data
Ewa Wieclawik
Vice Chairman of Supervisory Board3.7yrszł33.72kno data
Wojciech Aksman
Member of Supervisory Boardno datazł33.72kno data
Michal Jank
Supervisory Board Member1.4yrszł20.90kno data
3.7yrs
Average Tenure

Experienced Board: BCX's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 20:00
End of Day Share Price 2025/11/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioceltix S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Beata Szparaga-WasniewskaBiuro maklerskie mBanku